Are you a patient? Please see the GVHD section of our site for more information. Diseases / Graft versus host disease (GVHD)
GVHD Interactive Provider Network
The goal of the Interactive GVHD Provider Network is to connect GVHD specialists with community-based providers to share expertise and discuss cases in order to improve patient care.
The network is based on the ECHO Model™ (Extension for Community Healthcare Outcomes) which uses proven adult learning techniques and interactive video technology to connect community providers with specialists at academic centers in real-time collaborative sessions.
The sessions, designed around case-based learning and mentorship, help primary care and community-based practitioners gain the expertise required to provide needed services. These sessions will also be accredited for CME credits, an added benefit for the participants.
Each one-hour virtual session will include:
- Moderator to lead the program, introduce the speakers, and manage the discussion and questions
- Case presentation(s) presented by junior faculty or community provider
- Senior level clinician to provide a didactic presentation on the session topic
- Q & A and discussion with the panel and virtual participants
Target Audience:
Physicians of all specialties, nurse practitioners, physician assistants, and other healthcare professionals who treat patients with chronic GVHD welcome to attend monthly case-based telementoring presentations and discussions.
August Session of the GVHD Provider Network
Tuesday, August 16, 2022 – 8:00 am PT / 9:00 am MT / 10:00 am CT / 11:00 am ET
Topic: Mucocutaneous GVHD
Faculty:
Mary Flowers, MD - Professor Clinical Research Division, Fred Hutchinson Cancer Center, Seattle –
Betty Hamilton, MD – Associate Professor, Cleveland Clinic, Cleveland, OH
Andrew Trunk, MD – Hematology/Oncology Fellow, Cleveland Clinic, Cleveland, OH
Educational Objectives
After completing this CE activity, the participant should be better able to:
- Review symptoms and when to screen for mucocutaneous chronic GVHD
- Determine when to start treatment for mucocutaneous chronic GVHD
- Discuss options for managing long-term effects from mucocutaneous chronic GVHD
Future Monthly Session Topics:
- September 15: Sclerotic GVHD
- Bronchiolitis Obliterans (lung GVHD)
- Challenges of atypical manifestations of chronic GVHD
- Chronic GVHD Supportive care: infection, lipid abnormalities, cardiovascular, chronic fatigue, psychosocial
GVHD Interactive Provider Network Advisory Committee
- Steve Pavletic, MD, MS, National Cancer Institute – Chair
- Daniel Couriel, MD, MS, MBA, University of Utah
- Corey Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute
- Mary Flowers, MD, Fred Hutchinson Cancer Center
- Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Center
- Kirk Schultz, MD, University of British Columbia
Accreditation, Support, and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and Aplastic Anemia and MDS International Foundation. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 1.0 contact hour in the area of pharmacology.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Data Usage Notification
In order to support the growth of the ECHO movement, Project ECHO® collects participation data for each ECHO program. This data allows Project ECHO to measure, analyze, and report on the movement’s reach. It is used in reports, on maps and visualizations, for research, for communications and surveys, for data quality assurance activities, and for decision-making related to new initiatives. Please contact us at project.echo@hsc.utah.edu with any questions or concerns